Crinetics Pharmaceuticals, Inc.
FORMULATIONS OF A SOMATOSTATIN MODULATOR
Last updated:
Abstract:
Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
Status:
Application
Type:
Utility
Filling date:
25 Jan 2022
Issue date:
12 May 2022